71 related articles for article (PubMed ID: 2937789)
1. Lysis time and FDP immunoprecipitation by soluble and immobilized urokinase.
Senatore F; Bernath F
J Biomed Mater Res; 1986 Feb; 20(2):189-203. PubMed ID: 2937789
[TBL] [Abstract][Full Text] [Related]
2. Fibrinolytic activity of immobilized plasminogen activator.
Senatore FF; Bernath FR
Res Commun Chem Pathol Pharmacol; 1985 Aug; 49(2):295-304. PubMed ID: 4059655
[TBL] [Abstract][Full Text] [Related]
3. Clinical study of urokinase-bound fibrocollagenous tubes.
Senatore F; Bernath F; Meisner K
J Biomed Mater Res; 1986 Feb; 20(2):177-88. PubMed ID: 2937788
[TBL] [Abstract][Full Text] [Related]
4. Enhanced in vitro fibrinolytic activity of immobilized plasmin on collagen beads.
Shankar H; Senatore F; Zuniga P; Venkataramani E
J Biomed Mater Res; 1987 Jul; 21(7):897-912. PubMed ID: 2440893
[TBL] [Abstract][Full Text] [Related]
5. Parameters affecting optimum activity and stability of urokinase-bound fibrocollagenous tubes.
Senatore F; Bernath F
Biotechnol Bioeng; 1986 Jan; 28(1):64-72. PubMed ID: 18553843
[TBL] [Abstract][Full Text] [Related]
6. Urokinase bound to fibrocollagenous tubes: an in vitro kinetic study.
Senatore FF; Bernath FR
Biotechnol Bioeng; 1986 Jan; 28(1):58-63. PubMed ID: 18553842
[TBL] [Abstract][Full Text] [Related]
7. Immobilization of plasminogen activator, urokinase, on nylon.
Sugitachi A; Takagi K; Imaoka S; Kosaki G
Thromb Haemost; 1978 Apr; 39(2):426-36. PubMed ID: 580991
[TBL] [Abstract][Full Text] [Related]
8. Biological and thrombolytic properties of proenzyme and active forms of human urokinase--IV. Variability in fibrinolytic response of plasma of several mammalian species.
Lijnen HR; De Wreede K; Demarsin E; Collen D
Thromb Haemost; 1984 Aug; 52(1):31-3. PubMed ID: 6495261
[TBL] [Abstract][Full Text] [Related]
9. [Serial changes in hemostatic and fibrinolytic states induced by coronary thrombolytic therapy].
Goto S; Handa S; Abe S; Takahashi E; Kawai Y; Watanabe K; Yoshikawa T; Hori S; Ikeda Y
J Cardiol; 1993; 23(4):335-41. PubMed ID: 8064582
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the relative fibrinogenolytic, fibrinolytic and thrombolytic properties of tissue plasminogen activator and urokinase in vitro.
Matsuo O; Rijken DC; Collen D
Thromb Haemost; 1981 Jun; 45(3):225-9. PubMed ID: 7025339
[TBL] [Abstract][Full Text] [Related]
11. [Clinical significance of a new fibrinogen/fibrin degradation products(FDP) test using plasma samples for the diagnosis of fibrinogenolysis and fibrinolysis].
Imoto K; Yasumuro Y; Taki M; Suzuki N; Tanabe H; Ichikawa Y
Rinsho Byori; 2001 Mar; 49(3):283-9. PubMed ID: 11307330
[TBL] [Abstract][Full Text] [Related]
12. In vitro studies on the fibrinolytic, thrombolytic and fibrinogenolytic properties of a tissue plasminogen activator from guinea pig keratocytes.
Electricwala A; Ling RJ; Sutton PM; Griffiths B; Riley PA; Atkinson T
Thromb Haemost; 1985 Apr; 53(2):200-3. PubMed ID: 4040659
[TBL] [Abstract][Full Text] [Related]
13. The in vitro and in vivo behavior of urokinase immobilized onto collagen-synthetic polymer composite material.
Watanabe S; Shimizu Y; Teramatsu T; Murachi T; Hino T
J Biomed Mater Res; 1981 Jul; 15(4):553-63. PubMed ID: 7024280
[TBL] [Abstract][Full Text] [Related]
14. Antithrombotic mechanisms of urokinase immobilized polyurethane.
Kitamoto Y; Tomita M; Kiyama S; Inoue T; Yabushita Y; Sato T; Ryoda H; Sato T
Thromb Haemost; 1991 Jan; 65(1):73-6. PubMed ID: 2024241
[TBL] [Abstract][Full Text] [Related]
15. Incorporation of fragment X into fibrin clots renders them more susceptible to lysis by plasmin.
Schaefer AV; Leslie BA; Rischke JA; Stafford AR; Fredenburgh JC; Weitz JI
Biochemistry; 2006 Apr; 45(13):4257-65. PubMed ID: 16566600
[TBL] [Abstract][Full Text] [Related]
16. Fibrinolysis system in patients with bronchial asthma.
Banach-Wawrzeńczyk E; Dziedziczko A; Rość D
Med Sci Monit; 2000; 6(1):103-7. PubMed ID: 11208294
[TBL] [Abstract][Full Text] [Related]
17. [Intensification of the effect of exogenous plasminogen activators on lysis of fibrin blood clots due to a decrease in the level of alpha-2- antiplasmin by a plasmasorption method].
Ogloblina OG; Saburova OS; Semenova OA; Belova LA
Biokhimiia; 1994 Jan; 59(1):62-8. PubMed ID: 7509643
[TBL] [Abstract][Full Text] [Related]
18. Fibrinolysis in health and disease: severe abnormalities in systemic lupus erythematosus.
Glas-Greenwalt P; Kant KS; Allen C; Pollak VE
J Lab Clin Med; 1984 Dec; 104(6):962-76. PubMed ID: 6239000
[TBL] [Abstract][Full Text] [Related]
19. Comparative study of the activity of high and low molecular weight urokinase in the presence of fibrin.
Samama M; Castel M; Matsuo O; Hoylaerts M; Lijnen HR
Thromb Haemost; 1982 Feb; 47(1):36-40. PubMed ID: 7041325
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the intrinsic fibrinolytic properties of pro-urokinase through a study of plasmin-resistant mutant forms produced by site-specific mutagenesis of lysine(158).
Gurewich V; Pannell R; Broeze RJ; Mao J
J Clin Invest; 1988 Dec; 82(6):1956-62. PubMed ID: 2974047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
